Effects of Bifidobacterium Supplementation on Intestinal Microbiota Composition and the Immune Response in Healthy Infants
Overview
Authors
Affiliations
Background: Intestinal microbiotas are thought to be the most important source of maturational stimuli to the development of the immune system. However, few studies have focused on the development of T helper (Th) 1 immune response and antibody response to vaccinations in healthy infants, especially in a large cohort. Through this randomized, double-blind control trial, we investigated the effects of Bifidobacterium longum BB536 (BB536) supplementation on intestinal microbiota composition and the immune response in term infants.
Methods: In total, 300 healthy newborns were recruited, randomized and fed formula either supplemented with BB536 or with no supplementation. Stool samples were analyzed at months 2, 4 and 11. The representative cytokine for Th1 [interferon-γ (IFN-γ)] and Th2 [interleukin-4 (IL-4)] secretion cells were measured using enzyme-linked immunospot assay at 4 and 7 months of age. The antibody response to vaccines was measured at months 7 and 11.
Results: A total of 264 infants completed the study. The amount of bifidobacteria and the bifidobacteria/ Enterobacteriaceae ratio (B/E) were significantly higher in the BB536 supplementation group at months 2 and 4. The number of IFN-γ secretion cells and the ratio of IFN-γ/IL-4 secretion cells were increased in the BB536 supplementation group at 7 months. Moreover, the higher value of B/E in the early stages seems to be related to the increased Th1 response. No difference was observed between groups in the antibody response after vaccination.
Conclusion: BB536 has positive effects on establishing a healthy intestinal microbiota early in life, and it also plays an important role in improving the Th1 immune response.
Functional Significance of Probiotic Bacterial Interactions with Milk Fat Globules in a Human Host.
Wasana W, Waterland M, Everett D, Thum C Microorganisms. 2025; 13(2).
PMID: 40005590 PMC: 11857118. DOI: 10.3390/microorganisms13020223.
Pediatric kidney transplant recipients are at an increased risk for dysbiosis.
Yilmaz G, Saygili S, Agbas A, Yilmaz E, Varis A, Canpolat N Front Microbiol. 2025; 16:1499813.
PMID: 39949623 PMC: 11823477. DOI: 10.3389/fmicb.2025.1499813.
Qian J, Fang Z, Chang S, Zeng Z, Zhang J Eur J Clin Nutr. 2024; .
PMID: 39448812 DOI: 10.1038/s41430-024-01506-9.
Li Y, Molleston J, Lovato C, Wright J, Erickson I, Bui D PLoS Pathog. 2024; 20(10):e1012557.
PMID: 39356719 PMC: 11472911. DOI: 10.1371/journal.ppat.1012557.
Deciphering the Potential of Probiotics in Vaccines.
Xu C, Aqib A, Fatima M, Muneer S, Zaheer T, Peng S Vaccines (Basel). 2024; 12(7).
PMID: 39066349 PMC: 11281421. DOI: 10.3390/vaccines12070711.